Efficacy of influential factors in hemoporfin-mediated photodynamic therapy for facial port-wine stains.


Journal

The Journal of dermatology
ISSN: 1346-8138
Titre abrégé: J Dermatol
Pays: England
ID NLM: 7600545

Informations de publication

Date de publication:
Nov 2021
Historique:
revised: 16 06 2021
received: 03 02 2021
accepted: 15 07 2021
pubmed: 7 8 2021
medline: 4 11 2021
entrez: 6 8 2021
Statut: ppublish

Résumé

Hemoporfin-mediated photodynamic therapy (HMME-PDT) is a vascular-targeted treatment for port-wine stains (PWS). However, the efficacy of this has varied and is difficult to predict. The objective of this study was to evaluate the efficacy of influential factors associated with HMME-PDT and provide a suitable method for predicting the efficacy. Patients with facial PWS who underwent HMME-PDT were retrospective analyzed. A total of 212 patients (93 males) with mean age of 13.01 ± 12.67 years (range, 1-51) years were included. There were 143 cases with red, 56 cases with purple, and 13 cases with hypertrophic-type PWS. The number of HMME-PDT sessions ranged 1-6. The excellent response rate after 1-4 PDT sessions was 9.4%, 17.6%, 32.7%, and 42.9%, respectively. The number of PDT treatments is associated with efficacy, and patients who underwent treatment with more than three sessions had response better than those who underwent treatment with less than three sessions (p = 0.003). Response to HMME-PDT in patients of different ages, previous treatment history, lip involvement, and vessels morphology showed significant differences after two treatment sessions (p = 0.001, 0.03, 0.014, and 0.001, respectively), while patients of different sex, subtype, lesion size, location (medial, lateral, or mixed), or non-vascular morphology showed no significant differences. Logistic regression analysis confirmed that the patients with lip hypertrophy (p = 0.002), history of more than five times prior treatment (p = 0.003), fewer PDT sessions (<3) (p = 0.000002), linear vessels (p = 0.007), and reticular vessels (p = 0.0003) showed association with poor response of HMME-PDT. In conclusion, HMME-PDT is an effective treatment for PWS. Patients who had underwent treatment for more than five times prior, lip hypertrophy, and linear vessels or reticular vessels under dermoscope showed association with poor efficacy.

Identifiants

pubmed: 34355416
doi: 10.1111/1346-8138.16094
doi:

Substances chimiques

Hematoporphyrins 0
Photosensitizing Agents 0
hematoporphyrin monomethyl ether 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1700-1708

Informations de copyright

© 2021 Japanese Dermatological Association.

Références

Chen JK, Ghasri P, Aguilar G, van Drooge AM, Wolkerstorfer A, Kelly KM, et al. An overview of clinical and experimental treatment modalities for port wine stains. J Am Acad Dermatol. 2012;67:289-304.
Renfro L, Geronemus RG. Anatomical differences of port-wine stains in response to treatment with the pulsed dye laser. Arch Dermatol. 1993;129:182-8.
Jasim ZF, Handley JM. Treatment of pulsed dye laser-resistant port wine stain birthmarks. J Am Acad Dermatol. 2007;57:677-82.
Lanigan SW. Port-wine stains unresponsive to pulsed dye laser: explanations and solutions. Br J Dermatol. 1998;139:173-7.
Michel S, Landthaler M, Hohenleutner U. Recurrence of port-wine stains after treatment with the flashlamp-pumped pulsed dye laser. Br J Dermatol. 2000;143:1230-4.
Kelly KM, Kimel S, Smith T, Stacy A, Hammer-Wilson MJ, Svaasand LO, et al. Combined photodynamic and photothermal induced injury enhances damage to in vivo model blood vessels. Lasers Surg Med. 2004;34:407-13.
Qiu H, Gu Y, Wang Y, Huang N. Twenty years of clinical experience with a new modality of vascular-targeted photodynamic therapy for port wine stains. Dermatol Surg. 2011;37:1603-10.
Zhao YI, Tu P, Zhou G, Zhou Z, Lin X, Yang H, et al. Hemoporfin Photodynamic Therapy for Port-Wine Stain: A Randomized Controlled Trial. PLoS One. 2016;11:e0156219.
Gao K, Huang Z, Yuan KH, Zhang B, Hu ZQ. Side-by-side comparison of photodynamic therapy and pulsed-dye laser treatment of port-wine stain birthmarks. Br J Dermatol. 2013;168:1040-6.
Zhang B, Zhang TH, Huang Z, Li Q, Yuan KH, Hu ZQ. Comparison of pulsed dye laser (PDL) and photodynamic therapy (PDT) for treatment of facial port-wine stain (PWS) birthmarks in pediatric patients. Photodiagnosis Photodyn Ther. 2014;11:491-7.
Han Y, Ying H, Zhang X, Yu W, Cen Q, Chen X, et al. Retrospective study of photodynamic therapy for pulsed dye laser-resistant port-wine stains. J Dermatol. 2020;47:348-55.
Zhang M, Wu Q, Lin T, Guo L, Ge Y, Zeng R, et al. Hematoporphyrin monomethyl ether photodynamic therapy for the treatment of facial port-wine stains resistant to pulsed dye laser. Photodiagnosis Photodyn Ther. 2020;31:101820.
Sadeghinia A, Moghaddas S, Tavakolpour S, Teimourpour A, Danespazhooh M, Mahmoudi H. Treatment of port wine stains with 595-nm pulsed dye laser in 27 pediatric patients: a prospective study in the Iranian population. J Cosmet Laser Ther. 2019;21:373-7.
Wang X, Suo H, Gao Y, Du H, Fu Y, Sha S, et al. Correlation between the hemoporfin-mediated photodynamic treatment response and the dermoscopy vascular pattern in patients with a port-wine stain: a prospective study. J Eur Acad Dermatol Venereol. 2020;34:2795-801.
Huang Y, Yang J, Li Z, Zhang L, Sun LI, Bi M, et al. Dermoscopic features of port-wine stains:a study of 264 cases. Australas J Dermatol. 2021;62:21.
Li-Qiang G, Hua W, Si-Li N, Chun HT. A clinical study of HMME-PDT therapy in Chinese pediatric patients with port-wine stain. Photodiagnosis Photodyn Ther. 2018;23:102-5.
Savas JA, Ledon JA, Franca K, Chacon A, Nouri K. Pulsed dye laser-resistant port-wine stains: mechanisms of resistance and implications for treatment. Br J Dermatol. 2013;168:941-53.
Yu W, Ma G, Qiu Y, Chen H, Jin Y, Yang XI, et al. Why do port-wine stains (PWS) on the lateral face respond better to pulsed dye laser (PDL) than those located on the central face? J Am Acad Dermatol. 2016;74:527-35.
Li D-C, Nong X, Hu Z-Y, Fang T-W, Zhao T-T, Sun S-H, et al. Efficacy and related factors analysis in HMME-PDT in the treatment of port wine stains. Photodiagnosis Photodyn Ther. 2020;29:101649.
Walker EP, Butler PH, Pickering JW, Day WA, Fraser R, Van Halewyn CN. Histology of port wine stains after copper vapour laser treatment. Br J Dermatol. 1989;121:217-23.
Shirley MD, Tang H, Gallione CJ, Baugher JD, Frelin LP, Cohen B, et al. Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ. N Engl J Med. 2013;368:1971-9.
Tan W, Chernova M, Gao L, Sun V, Liu H, Jia W, et al. Sustained activation of c-Jun N-terminal and extracellular signal-regulated kinases in port-wine stain blood vessels. J Am Acad Dermatol. 2014;71:964-8.
Tan W, Nadora DM, Gao L, Wang G, Mihm MC, Nelson JS. The somatic GNAQ mutation (R183Q) is primarily located within the blood vessels of port wine stains. J Am Acad Dermatol. 2016;74:380-3.
Nikolaev SI, Vetiska S, Bonilla X, Boudreau E, Jauhiainen S, Rezai Jahromi B, et al. Somatic activating KRAS mutations in arteriovenous malformations of the brain. N Engl J Med. 2018;378:250-61.
Ma G, Yu Z, Liu F, Wang L, Yu W, Zhu J, et al. Somatic GNAQ mutation in different structures of port-wine macrocheilia. Br J Dermatol. 2018;179:1109-14.
Kono T, Frederick Groff W, Chan HH, Yamaki T, Sakurai H. Long-pulsed neodymium: yttrium-aluminum-garnet laser treatment for hypertrophic port-wine stains on the lips. J Cosmet Laser Ther. 2009;11:11-3.
Pu Y, Chen W, Yu Z. Research progress of Hemoporfin-part one: preclinical study. Photodiagnosis Photodyn Ther. 2012;9:180-5.
Wen L, Zhang Y, Zhang L, Liu X, Wang P, Shen S, et al. Application of different noninvasive diagnostic techniques used in HMME-PDT in the treatment of port wine stains. Photodiagnosis Photodyn Ther. 2019;25:369-75.
Li Y, Wang X, Liu Y, Tao J. Dermoscopy predicts outcome in hemoporfin mediated photodynamic therapy of port wine stains: a prospective observational study. J Am Acad Dermatol. 2020;83:1765-7.
Ankad BS, Arora P, Sardana K, Bhardwaj M. Differentiation of acquired port wine stain and angioma serpiginosum:a dermoscopic perspective. Int J Dermatol. 2019;58:e62-4.
Kwiek B, Rożalski M, Sieczych J, Paluch Ł, Kowalewski C, Ambroziak M. Predictive value of dermoscopy for the treatment of port-wine stains with large spot 532 nm laser. Lasers Surg Med. 2019;51:569-83.
Procaccini EM, Argenziano G, Staibano S, Ferrara G, Monfrecola G. Epiluminescence microscopy for port-wine stains: Pretreatment evaluation. Dermatology. 2001;203:329-32.
Bencini PL, Cazzaniga S, Galimberti MG, Zane C, Naldi L. Variables affecting clinical response to treatment of facial port-wine stains by flash lamp-pumped pulsed dye laser:the importance of looking beyond the skin. Lasers Med Sci. 2014;29:1365-70.
Motley RJ, Lanigan SW, Katugampola GA. Videomicroscopy predicts outcome in treatment of port-wine stains. Arch Dermatol. 1997;133:921-2.
Sevila A, Nagore E, Botella-Estrada R, Sanmartin O, Requena C, Serra-Guillen C, et al. Videomicroscopy of venular malformations (port-wine stain type): prediction of response to pulsed dye laser. Pediatr Dermatol. 2004;21:589-96.

Auteurs

Yuanbo Huang (Y)

Department of Dermatology and Venereology, Nanjing Medical University Affiliated Wuxi People's Hospital, Wuxi, China.

Jun Yang (J)

Department of Dermatology and Venereology, Nanjing Medical University Affiliated Wuxi People's Hospital, Wuxi, China.

Li Sun (L)

Department of Dermatology and Venereology, Nanjing Medical University Affiliated Wuxi People's Hospital, Wuxi, China.

Lichao Zhang (L)

Department of Dermatology and Venereology, Nanjing Medical University Affiliated Wuxi People's Hospital, Wuxi, China.

Mingye Bi (M)

Department of Dermatology and Venereology, Nanjing Medical University Affiliated Wuxi People's Hospital, Wuxi, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH